20-50891355-T-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001282531.3(ADNP):c.*50A>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.933 in 1,520,046 control chromosomes in the GnomAD database, including 661,873 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.95 ( 68907 hom., cov: 34)
Exomes 𝑓: 0.93 ( 592966 hom. )
Consequence
ADNP
NM_001282531.3 3_prime_UTR
NM_001282531.3 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0810
Genes affected
ADNP (HGNC:15766): (activity dependent neuroprotector homeobox) Vasoactive intestinal peptide is a neuroprotective factor that has a stimulatory effect on the growth of some tumor cells and an inhibitory effect on others. This gene encodes a protein that is upregulated by vasoactive intestinal peptide and may be involved in its stimulatory effect on certain tumor cells. The encoded protein contains one homeobox and nine zinc finger domains, suggesting that it functions as a transcription factor. This gene is also upregulated in normal proliferative tissues. Finally, the encoded protein may increase the viability of certain cell types through modulation of p53 activity. Alternatively spliced transcript variants encoding the same protein have been described. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 20-50891355-T-G is Benign according to our data. Variant chr20-50891355-T-G is described in ClinVar as [Benign]. Clinvar id is 1189012.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.979 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.951 AC: 144697AN: 152224Hom.: 68845 Cov.: 34 show subpopulations
GnomAD3 genomes
AF:
AC:
144697
AN:
152224
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.946 AC: 145586AN: 153852 AF XY: 0.942 show subpopulations
GnomAD2 exomes
AF:
AC:
145586
AN:
153852
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.931 AC: 1273189AN: 1367704Hom.: 592966 Cov.: 61 AF XY: 0.931 AC XY: 626263AN XY: 672884 show subpopulations
GnomAD4 exome
AF:
AC:
1273189
AN:
1367704
Hom.:
Cov.:
61
AF XY:
AC XY:
626263
AN XY:
672884
Gnomad4 AFR exome
AF:
AC:
30491
AN:
30872
Gnomad4 AMR exome
AF:
AC:
30743
AN:
31866
Gnomad4 ASJ exome
AF:
AC:
19223
AN:
21052
Gnomad4 EAS exome
AF:
AC:
38057
AN:
38066
Gnomad4 SAS exome
AF:
AC:
66899
AN:
72002
Gnomad4 FIN exome
AF:
AC:
37647
AN:
39704
Gnomad4 NFE exome
AF:
AC:
992483
AN:
1072144
Gnomad4 Remaining exome
AF:
AC:
53012
AN:
56802
Heterozygous variant carriers
0
5272
10545
15817
21090
26362
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
21294
42588
63882
85176
106470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.951 AC: 144818AN: 152342Hom.: 68907 Cov.: 34 AF XY: 0.951 AC XY: 70866AN XY: 74486 show subpopulations
GnomAD4 genome
AF:
AC:
144818
AN:
152342
Hom.:
Cov.:
34
AF XY:
AC XY:
70866
AN XY:
74486
Gnomad4 AFR
AF:
AC:
0.987064
AN:
0.987064
Gnomad4 AMR
AF:
AC:
0.95454
AN:
0.95454
Gnomad4 ASJ
AF:
AC:
0.919643
AN:
0.919643
Gnomad4 EAS
AF:
AC:
0.99942
AN:
0.99942
Gnomad4 SAS
AF:
AC:
0.931649
AN:
0.931649
Gnomad4 FIN
AF:
AC:
0.953484
AN:
0.953484
Gnomad4 NFE
AF:
AC:
0.92715
AN:
0.92715
Gnomad4 OTH
AF:
AC:
0.939451
AN:
0.939451
Heterozygous variant carriers
0
363
726
1088
1451
1814
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
912
1824
2736
3648
4560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3393
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at